Receipt of Deferred Consideration

Summary by AI BETAClose X

B.P. Marsh & Partners Plc has received the second tranche of deferred consideration amounting to £5.1 million from the sale of Aspira Corporate Solutions Limited, bringing the total proceeds received to date to £14.3 million, which includes £3.3 million in loan repayments and £11 million in deferred consideration. A final deferred payment of £5.1 million is anticipated in 2027, which will bring the total proceeds from the transaction to £16.1 million, exceeding the company's initial valuation of LEBC.

Disclaimer*

B.P. Marsh & Partners PLC
23 June 2026
 

23 June 2026

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

Receipt of Deferred Consideration

 

Further to the announcement made on 16 April 2024, B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to confirm that it has received the second tranche of deferred consideration of £5.1m in connection with the sale of Aspira Corporate Solutions Limited ("Aspira"), the wholly-owned subsidiary of LEBC Holdings Limited ("LEBC").

 

·    Received second tranche of deferred consideration of £5.1m 

·   B.P. Marsh has received total proceeds of £14.3m from the sale of Aspira to date, comprising £3.3m in loan repayments and £11m in deferred consideration

·    Next tranche due in 2027

 

Background of the Transaction

  

As previously reported, the sale of 100% of Aspira Corporate Solutions Limited ("Aspira") by LEBC Holdings Limited ("LEBC") to Titan Wealth Holdings Limited ("Titan Wealth") completed on 16 April 2024.

 

The transaction was structured with consideration payable over a three-year period and was expected to deliver proceeds at least in line with B.P. Marsh's valuation of LEBC as at 31 July 2023 of £15.9m.

 

Total proceeds received to date, including the second tranche of deferred consideration, amounts to £11.0m, with a final deferred consideration payment of £5.1m expected in 2027. No performance conditions are attached to the outstanding payment. Upon receipt, total proceeds from the transaction will amount to £16.1m. In addition, the Group received repayment in full of its £3.3m loan to LEBC in June 2025.

 

Oliver Bogue, a B.P. Marsh Board representative, stated: -

 

"This outcome is a testament to our patient, long-term investment approach and our disciplined focus on protecting shareholder capital. Having supported LEBC for almost 20 years, we are pleased to see the transaction continue to deliver value for shareholders."

 

For further information on B.P. Marsh, its strategy and current portfolio, please contact: 

 

B.P. Marsh & Partners Plc

Daniel Topping / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh-Pemberton / Peter Steel / James Todd

 

+44 (0)20 7496 3000

Joint Corporate Broker:

Investec Bank plc

Christopher Baird / Maria Gomez de Olea / Gordon Hamilton

 

+44 (0)20 7597 5970

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

About B.P. Marsh

 

B.P. Marsh & Partners Plc (AIM: BPM) is a specialist investor in early stage and small to medium-sized financial services intermediary businesses, with a particular focus on the insurance sector. Bridging the gap to traditional private equity funding rounds, B.P. Marsh takes a typical initial equity stake of up to £5m, often complemented by loans, and is able to tailor its investment model to each opportunity. Taking a long-term view of its investments, with an average holding period of around seven years, the Group supplies strategic insight and capital while empowering entrepreneurial management teams to grow their businesses.

 

The B.P. Marsh portfolio is diversified by geography and class of business, spanning insurance brokers, underwriting agencies and financial advisers in the UK, Europe, North America and other international markets. For further information, including details of the current portfolio and recent exits, please visit: www.bpmarsh.co.uk.

 

Forward-looking statements

 

This announcement may include statements, beliefs or opinions that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "targets", "aims", "continues", "expects", "intends", "hopes", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. No representation or warranty is made that any of these statements or forecasts will come to pass or that any forecast results will be achieved. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements contained in the announcement speak only as of their respective dates, reflect B.P. Marsh's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to B.P. Marsh's business, results of operations, financial position, liquidity, prospects, growth and strategies.

 

Except as required by any applicable law or regulation, B.P. Marsh expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement or any other forward-looking statements it may make whether as a result of new information, future developments or otherwise. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings